Quinolin-7-amine
Quinolin-7-amine structure
|
Common Name | Quinolin-7-amine | ||
|---|---|---|---|---|
| CAS Number | 580-19-8 | Molecular Weight | 144.173 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 324.3±15.0 °C at 760 mmHg | |
| Molecular Formula | C9H8N2 | Melting Point | 76 °C | |
| MSDS | USA | Flash Point | 176.1±7.6 °C | |
| Name | 7-Aminoquinoline |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 324.3±15.0 °C at 760 mmHg |
| Melting Point | 76 °C |
| Molecular Formula | C9H8N2 |
| Molecular Weight | 144.173 |
| Flash Point | 176.1±7.6 °C |
| Exact Mass | 144.068741 |
| PSA | 38.91000 |
| LogP | 1.26 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.708 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
| HS Code | 2933499090 |
|---|
|
~95%
Quinolin-7-amine CAS#:580-19-8 |
| Literature: Kelly, Michael G.; Kincaid, John; Janagani, Satyanarayana; Duncton, Matthew Patent: US2006/205773 A1, 2006 ; Location in patent: Page/Page column 29 ; |
|
~%
Quinolin-7-amine CAS#:580-19-8
Learn More
|
| Literature: US6750348 B1, ; Page column 41-42 ; US 6750348 B1 |
|
~%
Quinolin-7-amine CAS#:580-19-8 |
| Literature: Journal of Medicinal Chemistry, , vol. 50, # 15 p. 3497 - 3514 |
|
~%
Quinolin-7-amine CAS#:580-19-8 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 17 p. 4533 - 4536 |
|
~%
Quinolin-7-amine CAS#:580-19-8 |
| Literature: Journal fuer Praktische Chemie (Leipzig), , vol. <2> 48, p. 177 Chemische Berichte, , vol. 20, p. 3095 |
|
~%
Quinolin-7-amine CAS#:580-19-8 |
| Literature: Chemische Berichte, , vol. 20, p. 3095 |
| Precursor 6 | |
|---|---|
| DownStream 9 | |
CAS#:580-20-1
CAS#:25334-12-7
CAS#:612-61-3
CAS#:42464-80-2
CAS#:36164-42-8
CAS#:153856-89-4
CAS#:78105-42-7
CAS#:89770-32-1
CAS#:42606-36-0| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Name: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1):...
Source: NCGC
Target: thioredoxin reductase [Rattus norvegicus]
External Id: TRXR101
|
|
Name: qHTS for Inhibitors of Polymerase Iota
Source: NCGC
Target: DNA polymerase iota [Homo sapiens]
External Id: PolI100
|
|
Name: qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in...
Source: NCGC
Target: TDP1 protein [Homo sapiens]
External Id: TDP1100
|
|
Name: qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primar...
Source: NCGC
Target: 67.9K protein [Vaccinia virus]
External Id: Vaccinia-p2mCherry
|
|
Name: qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in...
Source: NCGC
Target: TDP1 protein [Homo sapiens]
External Id: TDP1101
|
|
Name: qHTS for Inhibitors of Polymerase Kappa
Source: NCGC
Target: DNA polymerase kappa [Homo sapiens]
External Id: PolK100
|
|
Name: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1):...
Source: NCGC
Target: thioredoxin reductase [Rattus norvegicus]
External Id: TRXR100
|
|
Name: qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary ...
Source: NCGC
Target: 67.9K protein [Vaccinia virus]
External Id: Vaccinia-p2Venus
|
|
Name: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen
Source: NCGC
Target: N/A
External Id: SMAD3201
|
|
Name: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).
Source: NCGC
Target: flap endonuclease 1 [Homo sapiens]
External Id: FEN1001
|
| 7-Quinolinamine (9CI) |
| 7-Quinolinamine |
| quinolin-7-amine |